[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352800-105":59,"doc-detail-352800-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","apoptosis-enhancement-in-mcf-7-cells-synergistic-effects-of-doxorubicin-and-the-novel-sulfonamide-zm-093","Apoptosis enhancement in MCF-7 cells - Synergistic effects of doxorubicin and the novel sulfonamide Zm-093","","Breast cancer research focuses on combination regimens that can improve efficacy while limiting toxicity. This study examines how doxorubicin (DOX) interacts with Zm-093, a novel sulfonamide derivative, to enhance apoptosis in breast cancer cell lines. Zm-093 synthesis and structure confirmation are paired with MTT-based viability testing and synergy evaluation via Compusyn. Apoptotic changes are characterized using western blotting, flow cytometry, and TUNEL assays. Results show a pronounced decrease in Bcl-2 and increased pro-apoptotic markers, supporting synergistic apoptosis induction.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/apoptosis-enhancement-in-mcf-7-cells-synergistic-effects-of-doxorubicin-and-the-novel-sulfonamide-zm-093/352800/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/apoptosis-enhancement-in-mcf-7-cells-synergistic-effects-of-doxorubicin-and-the-novel-sulfonamide-zm-093/352800.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",17,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the study?","Question",{"text":113,"@type":114},"To investigate whether doxorubicin and Zm-093 produce synergistic effects that enhance apoptosis induction in breast cancer cell lines, particularly MCF-7 cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was Zm-093 synthesized and confirmed?",{"text":118,"@type":114},"Zm-093 was synthesized, and its structure was confirmed using Fourier-transform infrared spectroscopy (FT-IR) and nuclear magnetic resonance (NMR) spectroscopy.",{"name":120,"@type":111,"acceptedAnswer":121},"Which experiments were used to assess apoptosis and synergy?",{"text":122,"@type":114},"Cell viability was measured with the MTT assay, synergy was evaluated using the combination index (CI) calculated in Compusyn, and apoptotic effects were analyzed with western blotting, flow cytometry, and TUNEL assays.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352800,1790784489,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Advancing Breast Cancer Research: Immunological, Pathological, and Pharmacological Perspectives for Improved Patient Outcomes-Original Research  \nApoptosis enhancement in MCF-7 cells: Synergistic effects of doxorubicin and the novel sulfonamide Zm-093  \nShabnam Pedarpour, Sevda Zarei and Hossein Ghafouri  \nInternational Journal of Immunopathology and Pharmacology Volume 40: 1–17  \n© The Author(s) 2026  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03946320261422036](DOI: 10.1177/03946320261422036)[ ](DOI: 10.1177/03946320261422036)[journals.sagepub.com/home/iji](journals.sagepub.com/home/iji)  \nAbstract  \nIntroduction: Breast cancer (BC) is a major global health issue. Combination therapies using chemical compounds have shown potential benefits, including reduced toxicity, slowed cancer cell growth, and improved treatment outcomes, compared to single-drug treatments.  \nObjectives: This study investigates the synergistic effects of doxorubicin (DOX) and Zm-093, a novel sulfonamide derivative with unique properties that offer potential advantages over existing sulfonamide compounds, including enhanced solubility and improved bioavailability, on apoptosis induction in BC cell lines.  \nMethods: Zm-093 was synthesized, and its structure was confirmed through Fourier-transform infrared spectroscopy (FT-IR) and nuclear magnetic resonance (NMR) spectroscopy. Cell viability was assessed using the MTT assay, while the combination index (CI) was calculated with Compusyn software to evaluate the synergistic interaction between DOXand Zm-093 in MCF-7 cells. The apoptotic effects of these compounds were further analyzed using western blotting, flow cytometry, and TUNEL assays.  \nResults: Notably, the combined treatment of DOX and Zm-093 at concentrations of 0.36 µM and 14.5 µM resulted in a 57% reduction in Bcl-2 expression compared to the control group. In contrast, expressions of pro-apoptotic proteins Bax and tBid, as well as caspase-3, increased significantly by 2.4, 3.3, and 5.7 times, respectively. Flow cytometry and TUNELassay results indicated that the combination therapy significantly enhanced early apoptosis while minimizing necrosis. Conclusion: These findings confirm that DOX and Zm-093 exhibit synergistic effects on apoptotic pathways in MCF- 7 cells, highlighting the potential of Zm-093 as a novel therapeutic agent with improved efficacy and reduced toxicity compared to existing sulfonamide compounds.  \nKeywords  \napoptosis, breast cancer, drug synergism, doxorubicin, sulfonamide, caspase-3  \nDate received: 27 December 2024; accepted: 21 January 2026  \nIntroduction  \nBC ranks as the most prevalent cancer among women, with an estimated 2.4 million (around 11% of all cancer diagnoses) new diagnoses reported in 2022. This malignancy is recognized globally as a leading cause of cancer-related mortality. In total, the year 2022 witnessed nearly 20 million new cancer cases and approximately 9.7 million cancer fatalities. Epidemiological data suggest that roughly one in five individuals,  \nregardless of sex, will receive a cancer diagnosis during their lifetime, while mortality rates indicate that about one in nine men and one in twelve women will succumb to the disease.1 BC is diagnosed  \nDepartment of Biology, Faculty of Science, University of Guilan, Rasht, Gilan, Iran  \nCorresponding author:  \nHossein Ghafouri, Department of Biology, Faculty of Science, University of Guilan, Rasht, Gilan 4193833697, Iran. [Email: H.ghafoori@guilan.ac.ir](Email: H.ghafoori@guilan.ac.ir)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use,  \nreproduction and distribution of the work without further permission provided the ","cbCaisO9l8X0Zl8v","https://ap.wps.com/l/cbCaisO9l8X0Zl8v","pdf",2017758,"English","# Abstract\n# Introduction\n# Objectives\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To investigate whether doxorubicin and Zm-093 produce synergistic effects that enhance apoptosis induction in breast cancer cell lines, particularly MCF-7 cells.\"},{\"question\":\"How was Zm-093 synthesized and confirmed?\",\"answer\":\"Zm-093 was synthesized, and its structure was confirmed using Fourier-transform infrared spectroscopy (FT-IR) and nuclear magnetic resonance (NMR) spectroscopy.\"},{\"question\":\"Which experiments were used to assess apoptosis and synergy?\",\"answer\":\"Cell viability was measured with the MTT assay, synergy was evaluated using the combination index (CI) calculated in Compusyn, and apoptotic effects were analyzed with western blotting, flow cytometry, and TUNEL assays.\"}]","Apoptosis enhancement in MCF-7 cells - Synergistic effects of doxorubicin and the novel sulfonamide Zm-093 | PDF",1790101422,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5382c6647b4a91d1ee2e0ba2dd932f4f.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/204efc3e2410b6178ef3e6b036b22f52.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66f28fadef8938fe0cdb6db94cdccb2d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/050b2323e35d8fc9f7c15b22f064a37c.webp",980,1306]